Leslie Iltgen

Investor Relations Contact at HENKEL AG & CO. KGAA

Health Technology

Consumer Non-Durables

Electronic Technology

Profile

Leslie Iltgen is currently the Head-Investor Relations at Henkel AG & Co. KGaA since 2022.
Prior to this, she held the position of Vice President-Investor Relations at Fresenius SE & Co. KGaA, STADA Arzneimittel AG, and Senior VP-Communications & Investor Relations at DEUTZ AG from 2018 to 2020.
She also worked as a Research Analyst at Bankhaus Lampe KG (Broker).
At Jenoptik AG, she was the Head-Investor Relations & Corporate Communications.

Leslie Iltgen active positions

Companies	Position	Start
HENKEL AG & CO. KGAA	Investor Relations Contact	2022-09-14

All active positions of Leslie Iltgen

Former positions of Leslie Iltgen

Companies	Position	End
DEUTZ AG	Investor Relations Contact	2020-11-30
JENOPTIK AG	Investor Relations Contact	-
FRESENIUS SE & CO. KGAA	Public Communications Contact	-
STADA ARZNEIMITTEL	Investor Relations Contact	-
Bankhaus Lampe KG (Broker)	Analyst-Equity	-

See the detail of Leslie Iltgen's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Leslie Iltgen's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	4
FRESENIUS SE & CO. KGAA	Health Technology
HENKEL AG & CO. KGAA	Consumer Non-Durables
JENOPTIK AG	Electronic Technology
DEUTZ AG	Producer Manufacturing

Private companies	2
STADA Arzneimittel AG STADA Arzneimittel AG Pharmaceuticals: OtherHealth Technology STADA Arzneimittel AG engages in the provision of healthcare and pharmaceutical products. It operates through the following segments: Generics, Consumer Healthcare, and Specialty. The Generics segment produces and distributes generic drugs. The Consumer Healthcare segment includes products such as OTC drugs, nutritional supplements and certain consumer healthcare products such as disinfectants and sunscreen. The Specialty segment includes branded generics, specialty generics, and biosimilars. Its brands include Zoflora, Grippostad, Nizoral, and Shampoo & Ladival. The company was founded on March 14, 1895 and is headquartered in Bad Vilbel, Germany.	Health Technology
Bankhaus Lampe KG (Broker)	Finance

Private companies